. 2011 Aug 4;10:131. doi: 10.1186/1476-511X-10-131

Table 4.

Fatty acid distribution of cellular lipids treated with different milk lipids at 24 h

	Control				ML_con								ML_alp

	0.25% EtOH				100 μM				200 μM				100 μM				200 μM
FAME [%]	Mean		SD		Mean		SD		Mean		SD		Mean		SD		Mean		SD

C14:0	1.67	±	0.32	^d	6.26	±	0.34	^b	8.33	±	0.61	^a	5.36	±	0.28	^c	6.86	±	0.46	^b
C14:1 c9	0.17	±	0.06	^c	0.55	±	0.09	^ab	0.67	±	0.15	^a	0.46	±	0.06	^b	0.54	±	0.07	^ab
C15:0	0.21	±	0.01	^c	0.81	±	0.06	^b	1.04	±	0.04	^a	0.85	±	0.04	^b	1.12	±	0.05	^a
C16:0	20.48	±	0.71	^d	30.34	±	1.27	^b	34.36	±	1.34	^a	24.56	±	0.65	^c	25.57	±	0.29	^c
C16:1 c9	15.44	±	0.97	^a	11.82	±	1.23	^b	9.45	±	1.09	^c	9.31	±	0.95	^c	6.96	±	0.73	^d
C16:2 t7,c9	-				-				-				0.07	±	0.01	^b	0.08	±	0.00	^a
C17:0	0.32	±	0.01	^a	0.54	±	0.04	^c	0.59	±	0.03	^b	0.59	±	0.04	^b	0.68	±	0.03	^d
C18:0	10.97	±	0.89	^a	9.39	±	0.32	^b	8.77	±	0.34	^b	9.03	±	0.21	^b	8.71	±	0.25	^b
C18:1 c9	36.95	±	0.87	^a	28.67	±	0.64	^d	26.09	±	0.27	^e	31.63	±	0.99	^b	30.27	±	0.34	^c
C18:1 c11	3.04	±	0.20	^a	1.77	±	0.15	^b	1.33	±	0.09	^a	1.84	±	0.05	^b	1.39	±	0.11	^a
C18:1 c12-15	-				0.29	±	0.15	^a	0.38	±	0.07	^a	0.41	±	0.13	^a	0.43	±	0.10	^a
C18:1 t4-8	-				0.02	±	0.01	^bc	0.04	±	0.02	^bc	0.07	±	0.04	^ab	0.10	±	0.05	^a
C18:1 t9	-				0.09	±	0.02	^c	0.12	±	0.03	^bc	0.15	±	0.04	^ab	0.20	±	0.06	^a
C18:1 t10	-				0.10	±	0.02	^b	0.14	±	0.03	^b	0.14	±	0.04	^b	0.20	±	0.03	^a
C18:1 t11 (VA)	-				0.18	±	0.04	^c	0.28	±	0.05	^c	1.86	±	0.25	^b	2.73	±	0.27	^a
C18:1 t12-16	-				0.35	±	0.09	^c	0.58	±	0.08	^b	0.56	±	0.13	^b	0.81	±	0.18	^a
C18:2 n-6	2.13	±	0.18	^a	1.91	±	0.12	^bc	1.73	±	0.07	^c	2.13	±	0.09	^a	2.00	±	0.04	^ab
C18:2 n-6 (t,t)	-				0.13	±	0.05	^d	0.22	±	0.03	^c	0.28	±	0.05	^b	0.42	±	0.03	^a
C18:2 c9,t11	0.07	±	0.02	^d	0.35	±	0.02	^c	0.40	±	0.02	^c	2.90	±	0.27	^b	3.57	±	0.18	^a
C18:2 t11,c13	-				-				-				0.15	±	0.02	^b	0.21	±	0.02	^a
C18:2 t9,t11	-				0.04	±	0.01	^c	0.04	±	0.01	^c	0.19	±	0.02	^b	0.21	±	0.02	^a
C18:3 n-3	0.20	±	0.03	^d	0.35	±	0.03	^c	0.39	±	0.03	^c	1.03	±	0.09	^b	1.26	±	0.06	^a
C20:0	0.35	±	0.02	^a	0.30	±	0.02	^b	0.28	±	0.01	^bc	0.30	±	0.01	^b	0.27	±	0.01	^c
C20:1 c9	0.41	±	0.05	^a	0.19	±	0.04	^cd	0.15	±	0.00	^d	0.26	±	0.02	^b	0.21	±	0.01	^bc
C20:3 n-6	0.97	±	0.12	^a	0.55	±	0.01	^b	0.38	±	0.01	^c	0.53	±	0.02	^b	0.36	±	0.02	^c
C20:4 n-6	1.82	±	0.19	^a	1.00	±	0.02	^b	0.66	±	0.03	^c	0.95	±	0.04	^b	0.63	±	0.04	^c
C20:5 n-3	0.53	±	0.05	^a	0.29	±	0.02	^bc	0.21	±	0.01	^d	0.33	±	0.02	^b	0.25	±	0.01	^cd
C22:5 n-3	1.04	±	0.15	^a	0.59	±	0.03	^b	0.42	±	0.01	^c	0.62	±	0.05	^b	0.43	±	0.03	^c
C22:6 n-3	1.31	±	0.12	^a	0.70	±	0.03	^b	0.45	±	0.03	^c	0.70	±	0.05	^b	0.43	±	0.04	^c
∑ SFA	35.66	±	1.27	^e	49.81	±	1.52	^b	55.66	±	1.15	^a	43.14	±	1.00	^d	45.98	±	0.53	^c
∑ MUFA	56.10	±	1.15	^a	44.15	±	1.60	^c	39.35	±	1.17	^d	46.84	±	0.86	^b	43.99	±	0.63	^c
∑ PUFA incl. CLA	8.24	±	0.78	^b	6.04	±	0.20	^c	4.99	±	0.06	^d	10.05	±	0.57	^a	10.03	±	0.17	^a
∑ PUFA n-3	3.20	±	0.34	^a	2.01	±	0.07	^d	1.51	±	0.04	^e	2.78	±	0.17	^b	2.47	±	0.04	^c
∑ PUFA n-6	4.97	±	0.47	^a	3.51	±	0.13	^b	2.82	±	0.06	^c	3.67	±	0.13	^b	3.07	±	0.04	^c
PUFA/SFA	0.23	±	0.03	^a	0.12	±	0.00	^b	0.09	±	0.00	^c	0.23	±	0.02	^a	0.22	±	0.00	^a
n-6/n-3	1.56	±	0.07	^c	1.75	±	0.07	^b	1.87	±	0.07	^a	1.32	±	0.03	^d	1.25	±	0.01	^d
∑ SFA + tFA	35.66	±	1.27	^d	50.75	±	1.62	^b	57.13	±	1.33	^a	46.28	±	1.17	^c	50.56	±	1.04	^b
∑ C18:1 (t)	-				0.74	±	0.16	^c	1.16	±	0.18	^c	2.78	±	0.45	^b	4.05	±	0.55	^a
C18:1 t9/t11	-				0.51	±	0.07	^a	0.42	±	0.07	^b	0.08	±	0.02	^c	0.07	±	0.02	^c
∑ CLA	0.07	±	0.02	^d	0.39	±	0.02	^c	0.44	±	0.02	^c	3.26	±	0.33	^b	3.99	±	0.17	^a
VA + C18:2 c9,t11	0.07	±	0.02	^d	0.52	±	0.05	^cd	0.68	±	0.06	^c	4.75	±	0.52	^b	6.30	±	0.40	^a
∑ BCFA	0.37	±	0.10	^d	1.36	±	0.13	^c	1.68	±	0.10	^b	1.72	±	0.17	^b	2.16	±	0.11	^a

FA distribution of HT-29 cells after incubation with milk lipids (ML conventional and ML Alpine) given as FFA-mixtures in ethanol. Means (n = 6) of FAME [%] significantly differ without the same letter ^{(a, b, c, d)}, two-way ANOVA Tukey post hoc test P < 0.05.